Cloning of the human phospholipase A2 activating protein (hPLAP) gene on the chromosome 9p21 melanoma deleted region

Gene

Volumn 239, Issue 1, 1999, Pages 155-161

  Ruiz, Anna ^a   Nadal, Marga ^a   Puig, Susana ^b   Estivill, Xavier ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

CMM; dbEST; Orthologue; Similarity

Indexed keywords

PHOSPHOLIPASE A2;

ARTICLE; CHROMOSOME 9P; ENZYME ACTIVATION; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MELANOMA; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CLONING, MOLECULAR; DATABASES, FACTUAL; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; RNA; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0032843734     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00354-6     Document Type: Article

References (37)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
2. Cannon-Albright L.A., Goldgar D.E., Meyer L.J., Lewis C.M., Anderson D.E., Fountain J.W., Hegi M.E., Wiseman R.W., Petty E.M., Bale A.E., Olopade O.I., Diaz M.O., Kwiatkowski D.J., Piepkorn M.W., Zone J.J., Skolnick M.H. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-22. Science. 258:1992;1148-1152.
3. Chopra A.K., Ribardo D.A., Wood T.G., Prusak D.J., Xu X.-J., Peterson J.W. Molecular characterization of cDNA for phospholipase A2-activating protein. Biochem. Biophys. Acta. 1444:1999;125-130.
4. Clark W.H., Reimer R.R., Greene M., Ainsworth A.M., Mastrangelo M.J. Origin of familial malignant melanomas from heritable melanocytic lesions. Arch. Dermatol. 114:1978;732-738.
5. Clark M.A., Ozgur L.E., Conway T.M., Dispoto J., Crooke S.T., Bomalaski J.S. Cloning of a phospholipase A2-activating protein. Proc. Natl. Acad. Sci. USA. 88:1991;5418-5422.
6. Clark J.D., Lin L.L., Kriz R.W., Ramesha C.S., Sultzman L.A., Lin A.Y., Milona N., Knopf J.L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
7. Dennis E.A. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1997;1-2.
8. Fountain J.W., Karayiorgou M., Ernstoff M.S., Kirkwood J.M., Vlock D.R., Titus-Ernstoff L., Bouchard B., et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci. USA. 89:1992;10557-10561.
9. Ghislain M., Dohmen R.J, Levy F., Varshavsky A. Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J. 15:1996;4884-4899.
10. Gish W., States D.J. Identification of protein coding regions by database similarity search. Nature Genet. 3:1993;266-272.
11. Gresham A., Masferrer J., Chen X., Leal-Khouri S., Pentland A.P. Increased synthesis of high-molecular-weight cPLA2 mediates early UV-induced PGE2 in human skin. Am. J. Physiol. 270:1996;1037-1050.
12. Haluska F.G., Hodi F.S. Molecular genetics of familial cutaneous melanoma. J. Clin. Oncol. 16:1998;670-682.
13. Horton P., Nakai K. Better prediction of protein cellular localization sites with the k nearest neighbours classifier. Ismb. 5:1997;147-152.
14. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
15. 2+-sensittive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410:1997;49-53.
16. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272:1997;16709-16712.
17. MacPhee M., Chepenik K.P., Liddell R.A., Nelson K.K., Siracusa L.D., Buchberg A.M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell. 8:1995;957-966.
18. Mochly-Rosen D., Miller K.G., Scheller R.H., Khaner H., Lopez J., Smith B.L. p65 fragments, homologous to the C2 region of protein kinase C, bind to the intracellular receptors for protein kinase C. Biochemistry. 31:(35):1992;8120-8124.
19. Morita I., Schindler M., Regier M.K., Otto J.C., Hori T., DeWitt D.L., Smith W.L. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 270:1995;10902-10908.
20. Nadal M., Mila M., Pritchard M., Mur A., Pujals J., Blouin J.L., Antonorakis S.E., Ballesta F., Estivill X. YAC and cosmid FISH mapping of an unbalanced translocation causing partial trisomy 21 and Down Syndrome. Human Genet. 98:1996;460-466.
21. Nalesfski E.A., Sultzan L.A., Martin D.M., Kriz R.W., Towler P.S., Knopf J.L., Clark J.D. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J. Biol. Chem. 269:1994;18239-18249.
22. Neer E.J., Schmidt C.J., Nambudripad R., Smith T.F. The ancient regulatory-protein family of WD-repeat proteins. Nature. 371:1994;297-300.
23. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
24. Ohta M., Berd D., Shimizu M., Nagai H., Coticelli M.G., Mastrangelo M., Shields J.A., Shields C.L., Croce C.M., Huebner K. Deletion mapping of chromosome region 9p21-9p22 surrounding the CDKN2 locus in melanoma. Int. J. Cancer. 65:1996;762-767.
25. Olopade O.I., Bohlander S.K., Pomykala H., Maltepe E., Van Melle E., Le Beau M.M., Diaz M.O. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics. 14:1992;437-443.
26. Puig S., Ruiz A., Lazaro C., Castel T., Lynch M., Palou J., Vilalta A., Weissenbach J., Mascaro J.M., Estivil X. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57:1995;395-402.
27. Rao G.N., Baas A.S., Glasgow W.C., Eling T.E., Runge M.S., Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269:1994;32586-32591.
28. Reed J.A., Loganzo F., Shea C.R., Walker G.J., Flores J.F., Glendening J.M., Bogdany J.K., Shiel M.J., Haluska F.G., Fountain J.W., Albino A.P. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 55:1995;2713-2718.
29. Reich R., Martin G.R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins. 51:1996;1-17.
30. Rigel D.S., Friedman R.J., Kopf A.W. Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J. Am. Acad. Dermatol. 35:1996;1012-1013.
31. Robinson B.S, Hii C.S, Poulos A., Ferrante A. Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology. 91:(2):1997;274-280.
32. Ron D., Chen C.H., Caldwell J., Jamieson L., Orr E., Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc. Natl. Acad. Sci. USA. 91:(3):1994;839-843.
33. Ruiz A., Puig S., Lynch M., Castel T., Estivill X. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic malignant melanoma. Int. J. Cancer. 76:1998;312-316.
34. Sala N., Espinosa-Parrilla Y. Analysis of the protein S gene in protein S deficiency. Hemostasis and Thrombosis Protocols. Methods in Molecular Medicine. Vol. 31:1999;Human Press, Totowa, NJ.
35. Wang H., Lemasters J.J., Herman B. Cloning of a rat cDNA encoding a protein with high homology to mouse phospholipase A2-activating protein. Gene. 161:1995;237-241.
36. Wiest J.S., Franklin W.A., Otstot J.T., Forbey K., Varella-Garcia M., Rao K., Drabkin H., Gemmill R., Ahrent S., Sidransky D., Saccomanno G., Fountain J.W., Anderson M.W. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res. 57:1997;1-6.
37. Woods J.W., Evans J.F., Ethier D., Scott S., Vickers P.J., Hearn L., Heibein J.A., Charleson S., Singer I.I. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:(6):1993;1935-1946.